Commentary · 27 Sep 2019
Conference abstractPublished 27 Jul 2015
Interrogating cancer transcriptome reprogramming
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recent high throughput interrogations of cancer landscape through programs such as The Cancer Genome Atlas (TCGA) have gained deeper understanding of cancer as a disease of heterogeneity of different stages of cell fate evolution and dedifferentiation. Epithelial tumors often exhibit mesenchymal features as a result of epithelial to mesenchymal transition (EMT), a process that can be driven by both genetic and epigenetic alterations in a form of network regulation. In ovarian cancer, loss of epithelial features and gain of a mesenchymal phenotype is associated with more aggressive tumor features. We performed an integrated genomic analysis which revealed a miRNA-regulatory network that further defined a robust integrated mesenchymal subtype associated with poor overall survival in 459 cases of serous ovarian cancer from TCGA and 560 cases from independent cohorts. Eight key miRNAs including miR-506, miR-141 and miR-200a were predicted to regulate 89% of the targets in this network. Follow-up functional experiments illustrate that miR-506 inhibited EMT by targeting SNAI2, a transcriptional repressor of E-cadherin as well as mesenchymal regulators vimentin and N-cadherin. MiR-506 also induced senescence by blocking CDK4/6-FoxM1 axis.We used our well-characterized nanoparticle platforms for systemic delivery of miR-506 in orthotopic OvCa mouse models and found such delivery to be highly effective for reduced tumor growth. Interestingly, mesenchymal tumors such as leiomyosarcoma and synovial sarcoma often exhibit epithelial features in a process of mesenchymal to epithelial transition (MET). MET in sarcoma is associated with improved prognosis. Therefore, reprogramming is an intrinsic hallmark of cancer. Understanding of these reprogramming promises leads to intervention that program cancer into an attractor stage that is more similar to normal cells or a stage that leads to irreversible cell death.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2022
Heterogeneity of circulating tumour cell neoplastic subpopulations interrogated by single-cell transcriptomics Heterogeneity of circulating tumour cell neoplastic subpopulations interrogated by single-cell transcriptomics
Commentary · 17 Sep 2025
Metabolic Reprogramming in Cancer Cells: Biochemical Perspectives
Commentary · 2 Apr 2025
Metabolic Reprogramming and Epigenetic Regulation in Prostate Cancer
Short communication · 26 Dec 2024
Epigenetic Reprogramming in Cancer: Tumour Cells Exploit Cellular Mechanisms
More from this journal
The newest in Transcriptomics: Open Access.
Commentary · 30 Dec 2025
Transcriptomic Biomarkers for Early Diagnosis and Prognosis of Diseases
Commentary · 30 Dec 2025
Metatranscriptomics for Understanding Microbial Community Functionality
Commentary · 30 Dec 2025
Single-Nucleus Transcriptomics in Neurological Disorder Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranscriptomics: Open Access
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Wei Zhang”

